• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

反义寡核苷酸的化学修饰研究。

Chemical modification study of antisense gapmers.

机构信息

Oligonucleotide Therapeutic Unit, Pfizer, Cambridge, MA, USA.

出版信息

Nucleic Acid Ther. 2012 Oct;22(5):344-59. doi: 10.1089/nat.2012.0366. Epub 2012 Aug 1.

DOI:10.1089/nat.2012.0366
PMID:22852836
Abstract

A series of insertion patterns for chemically modified nucleotides [2'-O-methyl (2'-OMe), 2'-fluoro (2'-F), methoxyethyl (MOE), locked nucleic acid (LNA), and G-Clamp] within antisense gapmers is studied in vitro and in vivo in the context of the glucocorticoid receptor. Correlation between lipid transfection and unassisted (gymnotic--using no transfection agent) in vitro assays is seen to be dependent on the chemical modification, with the in vivo results corresponding to the unassisted assay in vitro. While in vitro mRNA knockdown assays are typically reasonable predictors of in vivo results, G-Clamp modified antisense oligonucleotides have poor in vivo mRNA knockdown as compared to transfected cell based assays. For LNA gapmers, knockdown is seen to be highly sensitive to the length of the antisense and number of LNA insertions, with longer 5LNA-10DNA-5LNA compounds giving less activity than 3LNA-10DNA-3LNA derivatives. Additionally, the degree of hepatoxicity for antisense gapmers with identical sequences was seen to vary widely with only subtle changes in the chemical modification pattern. While the optimization of knockdown and hepatic effects remains a sequence specific exercise, general trends emerge around preferred physical properties and modification patterns.

摘要

在糖皮质激素受体的背景下,研究了一系列化学修饰核苷酸(2'-O-甲基(2'-OMe)、2'-氟(2'-F)、甲氧基乙基(MOE)、锁核酸(LNA)和 G-夹)在反义寡核苷酸中的插入模式。在体外,未辅助(使用非转染剂的电穿孔)的实验与脂质转染之间存在相关性,结果发现这种相关性取决于化学修饰,而体内结果与体外未辅助实验相对应。虽然体外 mRNA 敲低实验通常可以合理地预测体内结果,但与基于转染细胞的测定相比,G-夹修饰的反义寡核苷酸在体内的 mRNA 敲低效果较差。对于 LNA 寡核苷酸,敲低对反义的长度和 LNA 插入的数量非常敏感,5LNA-10DNA-5LNA 化合物的活性低于 3LNA-10DNA-3LNA 衍生物。此外,具有相同序列的反义寡核苷酸的肝毒性程度差异很大,而化学修饰模式的变化很小。虽然敲低和肝效应的优化仍然是一个序列特异性的问题,但在物理性质和修饰模式方面出现了一些共同的趋势。

相似文献

1
Chemical modification study of antisense gapmers.反义寡核苷酸的化学修饰研究。
Nucleic Acid Ther. 2012 Oct;22(5):344-59. doi: 10.1089/nat.2012.0366. Epub 2012 Aug 1.
2
Synthesis, physicochemical and biochemical studies of 1',2'-oxetane constrained adenosine and guanosine modified oligonucleotides, and their comparison with those of the corresponding cytidine and thymidine analogues.1',2'-氧杂环丁烷约束型腺苷和鸟苷修饰寡核苷酸的合成、物理化学及生物化学研究,以及它们与相应胞苷和胸苷类似物的比较。
J Am Chem Soc. 2004 Sep 22;126(37):11484-99. doi: 10.1021/ja048417i.
3
Comparison of hepatic transcription profiles of locked ribonucleic acid antisense oligonucleotides: evidence of distinct pathways contributing to non-target mediated toxicity in mice.锁核酸反义寡核苷酸的肝转录谱比较:非靶介导毒性在小鼠中相关途径的证据。
Toxicol Sci. 2014 Mar;138(1):234-48. doi: 10.1093/toxsci/kft278. Epub 2013 Dec 11.
4
Filling the gap in LNA antisense oligo gapmers: the effects of unlocked nucleic acid (UNA) and 4'-C-hydroxymethyl-DNA modifications on RNase H recruitment and efficacy of an LNA gapmer.填补锁核酸(LNA)反义寡核苷酸缺口嵌合体的空白:解锁核酸(UNA)和4'-C-羟甲基-DNA修饰对核糖核酸酶H募集及LNA缺口嵌合体疗效的影响
Mol Biosyst. 2009 Aug;5(8):838-43. doi: 10.1039/b903922h. Epub 2009 May 19.
5
On the in vitro and in vivo properties of four locked nucleic acid nucleotides incorporated into an anti-H-Ras antisense oligonucleotide.关于四种锁核酸核苷酸掺入抗H-Ras反义寡核苷酸后的体外和体内性质
Chembiochem. 2005 Jun;6(6):1104-9. doi: 10.1002/cbic.200400419.
6
Evaluating the Knockdown Activity of MALAT1 ENA Gapmers In Vitro.评价 MALAT1 ENA Gapmers 在体外的敲低活性。
Methods Mol Biol. 2020;2176:155-161. doi: 10.1007/978-1-0716-0771-8_11.
7
Ribonuclease H1-dependent hepatotoxicity caused by locked nucleic acid-modified gapmer antisense oligonucleotides.锁核酸修饰的gapmer反义寡核苷酸引起的核糖核酸酶H1依赖性肝毒性。
Sci Rep. 2016 Jul 27;6:30377. doi: 10.1038/srep30377.
8
Design of ENA gapmers as fine-tuning antisense oligonucleotides with sequence-specific inhibitory activity on mouse PADI4 mRNA expression.作为对小鼠PADI4 mRNA表达具有序列特异性抑制活性的微调反义寡核苷酸的ENA缺口嵌合体的设计。
Nucleic Acids Symp Ser (Oxf). 2006(50):319-20. doi: 10.1093/nass/nrl159.
9
Application of 2'-O-(2-N-Methylcarbamoylethyl) Nucleotides in RNase H-Dependent Antisense Oligonucleotides.2'-O-(2-甲氨酰基乙基)核苷酸在 RNase H 依赖性反义寡核苷酸中的应用。
Nucleic Acid Ther. 2018 Oct;28(5):307-311. doi: 10.1089/nat.2018.0738. Epub 2018 Jul 18.
10
Fine-tuning of ENA gapmers as antisense oligonucleotides for sequence-specific inhibition.作为用于序列特异性抑制的反义寡核苷酸的 ENA 间隙嵌合体的微调。
Oligonucleotides. 2007 Fall;17(3):291-301. doi: 10.1089/oli.2007.0078.

引用本文的文献

1
Oligonucleotide-Based Modulation of Macrophage Polarization: Emerging Strategies in Immunotherapy.基于寡核苷酸的巨噬细胞极化调控:免疫治疗中的新兴策略
Immun Inflamm Dis. 2025 May;13(5):e70200. doi: 10.1002/iid3.70200.
2
In Vitro Structure-Activity Relationship Stability Study of Antisense Oligonucleotide Therapeutics Using Biological Matrices and Nucleases.使用生物基质和核酸酶的反义寡核苷酸疗法的体外构效关系稳定性研究
Pharmacol Res Perspect. 2025 Jun;13(3):e70096. doi: 10.1002/prp2.70096.
3
Multispanning membrane protein SIDT2 increases knockdown activity of gapmer antisense oligonucleotides.
多跨膜蛋白SIDT2增强了间隙mer反义寡核苷酸的敲低活性。
Sci Rep. 2025 Jan 2;15(1):586. doi: 10.1038/s41598-024-84310-6.
4
Antisense oligonucleotides and their applications in rare neurological diseases.反义寡核苷酸及其在罕见神经系统疾病中的应用。
Front Neurosci. 2024 Sep 23;18:1414658. doi: 10.3389/fnins.2024.1414658. eCollection 2024.
5
Allele-Selective Thiomorpholino Antisense Oligonucleotides as a Therapeutic Approach for Fused-in-Sarcoma Amyotrophic Lateral Sclerosis.等位基因选择性噻唑啉鎓反义寡核苷酸作为融合性肉瘤肌萎缩侧索硬化症的治疗方法。
Int J Mol Sci. 2024 Aug 3;25(15):8495. doi: 10.3390/ijms25158495.
6
Favorable efficacy and reduced acute neurotoxicity by antisense oligonucleotides with 2',4'-BNA/LNA with 9-(aminoethoxy)phenoxazine.含9-(氨基乙氧基)吩恶嗪的2',4'-双环核酸/锁核酸反义寡核苷酸具有良好疗效并可降低急性神经毒性。
Mol Ther Nucleic Acids. 2024 Mar 18;35(2):102161. doi: 10.1016/j.omtn.2024.102161. eCollection 2024 Jun 11.
7
Towards Personalized Allele-Specific Antisense Oligonucleotide Therapies for Toxic Gain-of-Function Neurodegenerative Diseases.针对功能获得性毒性神经退行性疾病的个性化等位基因特异性反义寡核苷酸疗法
Pharmaceutics. 2022 Aug 16;14(8):1708. doi: 10.3390/pharmaceutics14081708.
8
Identification of nucleobase chemical modifications that reduce the hepatotoxicity of gapmer antisense oligonucleotides.鉴定降低 Gapmer 反义寡核苷酸肝毒性的碱基化学修饰。
Nucleic Acids Res. 2022 Jul 22;50(13):7224-7234. doi: 10.1093/nar/gkac562.
9
Quantitative Measurement of Cytosolic and Nuclear Penetration of Oligonucleotide Therapeutics.寡核苷酸治疗药物胞质和核内穿透的定量测量。
ACS Chem Biol. 2022 Feb 18;17(2):348-360. doi: 10.1021/acschembio.1c00830. Epub 2022 Jan 15.
10
Reduction of Off-Target Effects of Gapmer Antisense Oligonucleotides by Oligonucleotide Extension.寡核苷酸延伸降低 Gapmer 反义寡核苷酸的脱靶效应。
Mol Diagn Ther. 2022 Jan;26(1):117-127. doi: 10.1007/s40291-021-00573-z. Epub 2022 Jan 7.